Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model

Thrombosis Research

Volumn 127, Issue 3, 2011, Pages 210-213

  Arslan, Rana ^a   Bor, Zeynep ^a   Bektas, Nurcan ^a   Meriçli, Ali Hikmet ^b   Ozturk, Yusuf ^a  

^a ANADOLU UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antithrombotic effect; Carrageenan; Crataegus orientalis; Tail thrombosis model

Indexed keywords

ALCOHOL; ANTICOAGULANT AGENT; CARRAGEENAN; CRATAEGUS ORIENTALIS EXTRACT; HEPARIN; PLANT EXTRACT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRATAEGUS ORIENTALIS; DRUG ACTIVITY; DRUG INHIBITION; FEMALE; IN VIVO STUDY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; THROMBOSIS;

ANIMALS; CARRAGEENAN; CRATAEGUS; ETHANOL; FIBRINOLYTIC AGENTS; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; THROMBOSIS;

EID: 79951950674     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.11.028     Document Type: Article

References (31)

1. Ozcan M, Haciseferogullari H, Marakoglu T, Arslan D. Hawthorn (Crataegus spp.) fruit: some physical and chemical properties. J Food Eng 2005;69:409-13. (Pubitemid 40370253)
2. Bahorun T, Trotin F. Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994;60:323-6.
3. Bahorun T, Greiser B. Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung Drug Res 1996;46:1086-9. (Pubitemid 26391747)
4. Rakotoarison DA, Greissier B. Antioxidant activities of phenolic extracts from flowers, in vitro callus and cell suspension cultures of Crataegus monogyna. Pharmazie 1997;52:60-4. (Pubitemid 127491521)
5. Chang Q, Zuo Z, Harrison F, Chow MS, Hawthorn. J Clin Pharmacol 2002;42:605-12.
6. Vibes J, Lasserre J, Gleye J, Declume C. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxycantha (Hawthorn) flower heads. Prostaglandins Leukot Essent Fatty Acids 1994;50:173-5.
7. Hsiao G, Yen MH, Lee YM, Sheu JR. Antithrombotic effect of PMC, a potent alphatocopherol analogue on platelet plug formation in vivo. Br J Haematol 2002;117:699-704. (Pubitemid 34539249)
8. Jorgensen L. The role of platelets in the initial stages of atherosclerosis. J Thromb Haemost 2006;4:1443-9.
9. Mitchell RN, Cotran RS. Hemodinamic disorders, trombosis and shock. In: Cotran RS, Kumar V, Collins T, Robbins SL, editors. Robbins Pathologic Basis of Disease. Philadephia: W.B Saunders Company; 1999. p. 113-38.
10. Schussheim AE, Fuster V. Thrombosis, Antithrombotic Agents, and the Antithrombotic Approach in Cardiac Disease. Prog Cardiovasc Dis 1997;40:205-38.
11. Kod'ousek R, Jezdinsk J, Krajci D. Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin. Med Princ Pract 2007;16:360-6.
12. Bekemeier H, Gabor M, Hirschelmann R. Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis. Exp Pathol 1990;40:61-3. (Pubitemid 20346745)
13. Navarro DA, Stortz CA. Microwave-assisted alkaline modification of red seaweed galactans. Carbohydr Polym 2005;62:187-91. (Pubitemid 41543057)
14. Usov AI. Structural analysis of red seaweed galactans of agar and carrageenan groups. Food Hydrocolloids 1998;12:301-8.
15. Bekemeier H, Hirschelmann R, Giessler AJ. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances? Agents Actions 1985;16:446-51.
16. Hansra P, Moran EL, Fornasier VL, Bogoch ER. Carrageenan- induced arthritis in the rat. Inflammation 2000;24:141-55.
17. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
18. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76. (Pubitemid 27192468)
19. Hu S, Tian Q, Gu J, Sha J, Zhao D, Yan P, et al. A new kind of thrombus formation animal model in vivo. Zhonghua Xue Ye Xue Za Zhi 1993;14:541-2.
20. Howland RD, Mycek MJ. Drugs Affecting the Blood. In: Harvey RA, Champe PC, editors. Lippincott's Illustrated Reviews: Pharmacology. Baltimore: Lippincott Williams & Wilkins; 2006. p. 230-4.
21. Silbernagl S, Despopoulos A. Color Atlas of Physiology. 6th ed. Stuttgart: Georg Thieme Verlag KG; 2009. p. 104.
22. Yao M, Ritchie HE, Brown-Woodman PD. A reproductive screening test of hawthorn. J Ethnopharmacol 2008;118:127-32.
23. Melikoglu G, Mericli F, Mericli AH. Flavonoids of Crataegus orientalis. Boll Chim Farm 1999;138:351-2. (Pubitemid 29528776)
24. Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 1984;33:1525-30. (Pubitemid 14105028)
25. Polette A, Lemaitre D, Lagarde M, Vericel E. N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins. Thromb Haemost 1996;75:945-9. (Pubitemid 26355352)
26. Akyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem1987;262:5592-5.
27. Jacobson KA, Moro S, Manthey JA, West PL, Ji XD. Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol 2002;505:163-71. (Pubitemid 34526433)
28. Mruk JS, Webster MWI, Heras M, Reid JM, Grill DE, Chesebro JH. Flavone-8-acetic acid (flavonoid) profoundly reduces platelet dependent thrombosis and vasoconstriction after deep arterial injury in vivo. Circulation 2000;10:324-8. (Pubitemid 30054161)
29. Guerrero JA, Lozano ML, Castillo J, Benavente-Garcia O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 2005;3:369-76. (Pubitemid 41623628)
30. Camici CG, Steffel J, Akhmedov A, Schafer N, Baldinger J, Schulz U, Shojaati K, Matter CM, Yang Z, Lüscher TF, Tanner FC. Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents. Circulation 2006;114:1512-21.
31. Asmis L, Tanner FC, Sudano I, Lüscher TF, Camici GG. DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochem Biophys Res Commun 2010;391:1629-33.